Can Injective sustain its 35% rally? INJ’s move to $6.09 depends on…
Injective (INJ) recently experienced a significant 35% rally, climbing from $2.97 to $4.02, supported by a 57% surge in trading volume. This bullish momentum was driven by news of a $2 million INJ acquisition by Pineapple, which also announced $20.79 million in capital reserves for further accumulation, and the launch of Injective’s real-time EVM mainnet upgrade.
Despite the short-term gains, the long-term trend remains bearish, with INJ forming lower highs and lower lows since September 2025. Technical indicators like the RSI show a potential momentum shift, but the CMF indicates ongoing capital outflows. Key resistance levels are at $4.16 and $6.09.
In the short term, a retracement toward $3.44–$3.28 is likely, which may later provide a foundation for a move toward higher resistances. A breakout above $4.16 and $6.09 is necessary to establish a sustained uptrend.
ambcrypto02/22 13:01